General Information of DTT (ID: TTMYWL7)

DTT Name Cyclin-dependent kinase 3 (CDK3) DTT Info
Gene Name CDK3

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
RGB-286638 DMEGOQP Haematological malignancy 2B33.Y Phase 1 [1]
------------------------------------------------------------------------------------
3 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Nitrogen mustard derivative 1 DMXDSYU N. A. N. A. Patented [2]
Oxazolyl methylthiothiazole derivative 1 DMZM6FW N. A. N. A. Patented [2]
PMID26161698-Compound-17 DMB92RA N. A. N. A. Patented [2]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs. Leukemia. 2013 Dec;27(12):2366-75.
2 Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).Expert Opin Ther Pat. 2015;25(9):953-70.